查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1554195

2 型糖尿病治疗市场规模、份额、趋势分析报告：按药物类别、给药途径、分销管道、地区、细分市场预测，2024-2030 年

Type 2 Diabetes Mellitus Treatment Market Size, Share & Trends Analysis Report By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists), By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 95 Pages | 商品交期: 2-10个工作天内

价格

2 型糖尿病治疗市场成长与趋势：

Grand View Research, Inc.的研究报告显示，预计到2030年，全球2型糖尿病治疗市场规模将达到919亿美元，2024年至2030年复合年增长率为6.9%。

这种扩张是由日益增加的全球 2 型糖尿病负担和治疗方案的进步所推动的。由于不良饮食习惯和缺乏运动等生活方式的改变导致肥胖率增加，2 型糖尿病的发生率正在上升。根据国际糖尿病联盟（IDF）统计，全球有超过 5 亿人患有糖尿病，其中约 90% 患有第 2 型糖尿病。患者数量的不断增加刺激了对有效和创新治疗的需求。

糖尿病管理的进步正在推动市场成长。 GLP-1 受体促效剂和 SGLT2 抑制剂等新型治疗药物的开发显着改善了治疗效果。这些药物不仅可以降低血糖值，还可以提供其他益处，例如心血管保护和体重管理。新的胰岛素配方和技术（例如连续血糖监测仪和胰岛素帮浦）的引入正在进一步改善患者照护并推动市场扩张。例如，2023年1月，食品药物管理局（FDA）核准诺和诺德的糖尿病治疗药物Libersus作为降低血糖值的第一线药物。这项核准使 2 型糖尿病患者能够与他们的医疗保健提供者合作，将 Libersus 纳入他们的治疗计划中，为他们提供从症状出现时就控制病情的新选择。

此外，增加医疗保健投资和改善糖尿病治疗的机会也有助于市场成长。政府和医疗保健组织正在投资糖尿病管理计划、公众意识提升宣传活动和医疗保健基础设施。这些努力旨在加强早期诊断、治疗顺从性和整体患者管理。

2 型糖尿病治疗市场报告亮点

  • 2023年，胰岛素製剂在第2型糖尿病治疗市场中占最大销售份额，达32.8%。这一增长主要是由于久坐的生活方式导致全球 2 型糖尿病盛行率不断增加。
  • 预计在预测期内，皮下注射将在第 2 型糖尿病治疗市场中实现最高的复合年增长率 (9.4%)。
  • 2023年，零售药局业务在第2型糖尿病治疗市场中占最大销售份额，约70.0%。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 2 型糖尿病治疗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 2型糖尿病治疗市场、市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章 2 型糖尿病治疗市场：依药物类别估算与趋势分析

  • 全球第 2 型糖尿病治疗市场：药物类别仪表板
  • 全球第2型糖尿病治疗市场：药物类别波动分析
  • 全球 2 型糖尿病治疗市场：按药物类别分類的收益
  • 胰岛素
  • DPP-4抑制剂
  • GLP-1受体促效剂
  • SGLT2抑制剂
  • 其他的

第五章 2型糖尿病治疗市场：依给药途径估计与趋势分析

  • 全球第 2 型糖尿病治疗市场：途径仪表板
  • 全球第2型糖尿病治疗市场：给药途径变化分析
  • 按途径的收益
  • 口服
  • 皮下的
  • 静脉

第六章 2型糖尿病治疗市场：依通路估算与趋势分析

  • 全球 2 型糖尿病治疗市场：分销通路仪表板
  • 全球第2型糖尿病治疗市场：通路波动分析
  • 按分销管道分類的收益
  • 零售药房
  • 医院药房
  • 其他的

第七章 2型糖尿病治疗市场：按药物类别、给药途径和分销管道分類的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 2023年主要企业市场占有率分析
    • AstraZeneca PLC
    • Boehringer Ingelheim International GmbH
    • Eli Lilly and Co.
    • Merck &Co. Inc
    • Novartis AG
    • Novo Nordisk AS
    • Sanofi SA
    • Takeda Pharmaceutical Co. Ltd
Product Code: GVR-4-68040-430-4

Type 2 Diabetes Mellitus Treatment Market Growth & Trends:

The global type 2 diabetes mellitus treatment market size is anticipated to reach USD 91.9 billion by 2030, growing at a CAGR of 6.9% from 2024 to 2030, according to a report by Grand View Research, Inc. This expansion is driven by the increasing global burden of type 2 diabetes and advancements in treatment options. As lifestyle changes, such as poor dietary habits and physical inactivity, contribute to higher obesity rates, the incidence of type 2 diabetes is on the rise. According to the International Diabetes Federation (IDF), over 500 million people worldwide are affected by diabetes, with Type 2 diabetes accounting for approximately 90% of these cases. This growing patient population fuels demand for effective and innovative treatments.

Advancements in diabetes management are boosting market growth. The development of new classes of medications, such as GLP-1 receptor agonists and SGLT2 inhibitors, has significantly improved treatment outcomes. These therapies not only lower blood glucose levels but also offer additional benefits like cardiovascular protection and weight management. The introduction of novel insulin formulations and technologies, including continuous glucose monitors and insulin pumps, further enhances patient care and drives market expansion. For instance, in January 2023, the Food and Drug Administration (FDA) approved Novo Nordisk's diabetes medication, Rybelsus, as a first-line treatment for lowering blood sugar levels. With this approval, individuals with Type 2 diabetes, in collaboration with their healthcare providers, can now incorporate Rybelsus early in their treatment plan, offering a new option for managing their condition from the onset.

In addition, increasing healthcare investments and improved access to diabetes care contribute to market growth. Governments and healthcare organizations are investing in diabetes management programs, public awareness campaigns, and healthcare infrastructure improvements. These efforts aim to enhance early diagnosis, treatment adherence, and overall patient management.

Type 2 Diabetes Mellitus Treatment Market Report Highlights:

  • In 2023, the insulin segment accounted for the largest revenue share of 32.8% in diabetes mellitus, type 2 treatment market. This growth primarily is attributed to the rising prevalence of type 2 diabetes around the world due to sedentary lifestyle
  • Subcutaneous are anticipated to achieve the highest CAGR of 9.4% in the diabetes mellitus, type 2 treatment market during the forecast period
  • The retail pharmacies segment accounted for the largest revenue share of around 70.0% in diabetes mellitus, type 2 treatment market in 2023

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Class
    • 1.2.2. Route of Administration
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Drug Class Outlook
    • 2.2.2. Route of Administration
    • 2.2.3. Distribution Channel
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Type 2 Diabetes Mellitus Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence of Diabetes
      • 3.2.1.2. Advancements In Treatment Options
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Treatment Cost
      • 3.2.2.2. Patient Non-Adherence
  • 3.3. Type 2 Diabetes Mellitus Treatment Market, Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Type 2 Diabetes Mellitus Treatment Market: Drug Class Estimates & Trend Analysis

  • 4.1. Global Type 2 Diabetes Mellitus Treatment Market: Drug Class Dashboard
  • 4.2. Global Type 2 Diabetes Mellitus Treatment Market: Drug Class Movement Analysis
  • 4.3. Global Type 2 Diabetes Mellitus Treatment Market by Drug Class, Revenue
  • 4.4. Insulin
    • 4.4.1. Insulin market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. DPP-4 Inhibitors
    • 4.5.1. DPP-4 Inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. GLP-1 Receptor Agonists
    • 4.6.1. GLP-1 Receptor Agonists market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. SGLT2 Inhibitors
    • 4.7.1. SGLT2 Inhibitors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Type 2 Diabetes Mellitus Treatment Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Global Type 2 Diabetes Mellitus Treatment Market: Route of Administration Dashboard
  • 5.2. Global Type 2 Diabetes Mellitus Treatment Market: Route of Administration Movement Analysis
  • 5.3. Global Type 2 Diabetes Mellitus Treatment Market Estimates and Forecasts, By Route of Administration, Revenue (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Subcutaneous
    • 5.5.1. Subcutaneous market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Intravenous
    • 5.6.1. Intravenous market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Global Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Dashboard
  • 6.2. Global Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Movement Analysis
  • 6.3. Global Type 2 Diabetes Mellitus Treatment Market Estimates and Forecasts, By Distribution Channel, Revenue (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Hospital Pharmacies
    • 6.5.1. Hospital Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other
    • 6.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Type 2 Diabetes Mellitus Treatment Market: Regional Estimates & Trend Analysis by Drug Class, Route of Administration, and Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key company market share analysis, 2023
    • 8.2.3. AstraZeneca PLC
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Boehringer Ingelheim International GmbH
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Eli Lilly and Co.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Merck & Co. Inc
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Novartis AG
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Novo Nordisk AS
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Sanofi SA
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Takeda Pharmaceutical Co. Ltd
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 4 North America Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 5 North America Type 2 Diabetes Mellitus Treatment Market, Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 7 U.S. Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 U.S. Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 Canada Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 10 Canada Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 11 Canada Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 12 Mexico Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 13 Mexico Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 14 Mexico Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 Europe Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Europe Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Europe Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Germany Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 20 Germany Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 21 Germany Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 UK Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 23 UK Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 UK Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 France Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 26 France Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 27 France Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Italy Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 29 Italy Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 Italy Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 Spain Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 32 Spain Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Spain Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 Denmark Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 35 Denmark Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 36 Denmark Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Sweden Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 38 Sweden Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 39 Sweden Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Norway Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Norway Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 42 Norway Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 China Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 48 China Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 China Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Japan Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 51 Japan Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 52 Japan Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 India Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 54 India Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 55 India Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 South Korea Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 57 South Korea Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 South Korea Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Australia Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 60 Australia Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Australia Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Thailand Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 63 Thailand Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 64 Thailand Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Latin America Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Latin America Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Latin America Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Brazil Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 Brazil Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 Brazil Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 73 Argentina Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Argentina Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 MEA Type 2 Diabetes Mellitus Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 76 MEA Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 77 MEA Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 MEA Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 South Africa Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 80 South Africa Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 81 South Africa Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 UAE Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 86 UAE Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 UAE Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Type 2 Diabetes Mellitus Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Type 2 Diabetes Mellitus Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Type 2 Diabetes Mellitus Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Type 2 Diabetes Mellitus Treatment Market, Market: Market Outlook
  • Fig. 14 Type 2 Diabetes Mellitus Treatment Market, Competitive Insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Type 2 diabetes mellitus treatment Market Driver Impact
  • Fig. 18 Type 2 Diabetes Mellitus Treatment Market Restraint Impact
  • Fig. 19 Type 2 Diabetes Mellitus Treatment Market Strategic Initiatives Analysis
  • Fig. 20 Type 2 Diabetes Mellitus Treatment Market: Drug Class Movement Analysis
  • Fig. 21 Type 2 Diabetes Mellitus Treatment Market: Drug Class Outlook And Key Takeaways
  • Fig. 22 Insulin market estimates and forecast, 2018 - 2030
  • Fig. 23 DPP-4 inhibitors market estimates and forecast, 2018 - 2030
  • Fig. 24 GLP-1 receptor agonists market estimates and forecast, 2018 - 2030
  • Fig. 25 SGLT2 inhibitors market estimates and forecast, 2018 - 2030
  • Fig. 26 Other market estimates and forecast, 2018 - 2030
  • Fig. 27 Type 2 Diabetes Mellitus Treatment Market: Route of Administration Movement Analysis
  • Fig. 28 Type 2 Diabetes Mellitus Treatment Market: Route of Administration Outlook And Key Takeaways
  • Fig. 29 Oral market estimates and forecast, 2018 - 2030
  • Fig. 30 Subcutaneous market estimates and forecast, 2018 - 2030
  • Fig. 31 Intravenous market estimates and forecast, 2018 - 2030
  • Fig. 32 Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Movement Analysis
  • Fig. 33 Type 2 Diabetes Mellitus Treatment Market: Distribution Channel Outlook And Key Takeaways
  • Fig. 34 Retail pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 35 Hospital pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 36 Other market estimates and forecast, 2018 - 2030
  • Fig. 37 Global Type 2 Diabetes Mellitus Treatment Market: Regional Movement Analysis
  • Fig. 38 Global Type 2 Diabetes Mellitus Treatment Market: Regional Outlook And Key Takeaways
  • Fig. 39 Global Type 2 Diabetes Mellitus Treatment market share and leading players
  • Fig. 40 North America, by country
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. key country dynamics
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico key country dynamics
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK key country dynamics
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Germany key country dynamics
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France key country dynamics
  • Fig. 54 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Italy key country dynamics
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Spain key country dynamics
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Denmark key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Sweden key country dynamics
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Norway key country dynamics
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 China key country dynamics
  • Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 India key country dynamics
  • Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand key country dynamics
  • Fig. 73 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Korea key country dynamics
  • Fig. 75 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Australia key country dynamics
  • Fig. 77 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Brazil key country dynamics
  • Fig. 80 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Argentina key country dynamics
  • Fig. 82 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa key country dynamics
  • Fig. 85 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Saudi Arabia key country dynamics
  • Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 UAE key country dynamics
  • Fig. 89 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Kuwait key country dynamics
  • Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Market share of key market players- Type 2 Diabetes Mellitus Treatment market